NCT03687099View on ClinicalTrials.gov

Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2018

Primary Completion Date

November 8, 2019

Study Completion Date

November 8, 2019

Conditions
Glioblastoma
Interventions
OTHER

no intervention

Histological samples from 10 GBM removed from patients with long-term survival and 10 GBM removed from patients with short-term survival

Trial Locations (1)

80054

CHU Amiens-Picardie, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT03687099 - Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma | Biotech Hunter | Biotech Hunter